Amolyt Pharma
2Patents
2Active
2Granted
41Portfolio score
Filing activity: Feb 5, 2018 → May 23, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11192932B2 | Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US10947285B2 | Compounds, compositions and uses thereof for improvement of bone disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.